This miRNA’s role in regulating the CASR/STAT3 axis indicates its potential as a therapeutic target to counteract chemoresistance in ovarian cancer [62] (Table 1 and Fig. 5B). This evidence concerns the gene STAT3 and ovarian carcinoma.